Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 1, no: 9 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0005794 | Golgi apparatus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4IAK1
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 1 |
GO:0006605 | protein targeting | 5 | 1 |
GO:0006612 | protein targeting to membrane | 5 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0006810 | transport | 3 | 1 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0008104 | protein localization | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018198 | peptidyl-cysteine modification | 6 | 1 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7 | 1 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 7 | 1 |
GO:0018345 | protein palmitoylation | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043543 | protein acylation | 5 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0051668 | localization within membrane | 3 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0072657 | protein localization to membrane | 4 | 1 |
GO:0090150 | establishment of protein localization to membrane | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016409 | palmitoyltransferase activity | 5 | 11 |
GO:0016417 | S-acyltransferase activity | 5 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016746 | acyltransferase activity | 3 | 11 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 11 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 11 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 152 | 154 | PF00675 | 0.559 |
CLV_PCSK_FUR_1 | 149 | 153 | PF00082 | 0.573 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 152 | 154 | PF00082 | 0.556 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.637 |
DOC_CYCLIN_RxL_1 | 109 | 120 | PF00134 | 0.460 |
DOC_MAPK_gen_1 | 109 | 119 | PF00069 | 0.552 |
DOC_MAPK_MEF2A_6 | 109 | 118 | PF00069 | 0.586 |
DOC_PP2B_LxvP_1 | 108 | 111 | PF13499 | 0.460 |
DOC_PP4_FxxP_1 | 176 | 179 | PF00568 | 0.509 |
DOC_SPAK_OSR1_1 | 153 | 157 | PF12202 | 0.333 |
DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.432 |
LIG_14-3-3_CanoR_1 | 136 | 140 | PF00244 | 0.335 |
LIG_14-3-3_CanoR_1 | 169 | 179 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 27 | 35 | PF00244 | 0.353 |
LIG_Actin_WH2_2 | 121 | 138 | PF00022 | 0.441 |
LIG_BRCT_BRCA1_1 | 160 | 164 | PF00533 | 0.409 |
LIG_BRCT_BRCA1_1 | 172 | 176 | PF00533 | 0.450 |
LIG_eIF4E_1 | 56 | 62 | PF01652 | 0.447 |
LIG_FHA_2 | 31 | 37 | PF00498 | 0.330 |
LIG_GBD_Chelix_1 | 97 | 105 | PF00786 | 0.233 |
LIG_LIR_Apic_2 | 173 | 179 | PF02991 | 0.495 |
LIG_LIR_Gen_1 | 131 | 140 | PF02991 | 0.464 |
LIG_LIR_Gen_1 | 14 | 24 | PF02991 | 0.465 |
LIG_LIR_Gen_1 | 93 | 101 | PF02991 | 0.548 |
LIG_LIR_Nem_3 | 131 | 135 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 138 | 142 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 14 | 20 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 93 | 97 | PF02991 | 0.533 |
LIG_NRBOX | 5 | 11 | PF00104 | 0.507 |
LIG_Pex14_2 | 164 | 168 | PF04695 | 0.364 |
LIG_Pex14_2 | 172 | 176 | PF04695 | 0.410 |
LIG_PTB_Apo_2 | 72 | 79 | PF02174 | 0.447 |
LIG_SH2_CRK | 137 | 141 | PF00017 | 0.350 |
LIG_SH2_CRK | 142 | 146 | PF00017 | 0.366 |
LIG_SH2_CRK | 181 | 185 | PF00017 | 0.479 |
LIG_SH2_STAP1 | 137 | 141 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 56 | 59 | PF00017 | 0.447 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.434 |
LIG_SUMO_SIM_par_1 | 115 | 120 | PF11976 | 0.487 |
LIG_SUMO_SIM_par_1 | 8 | 14 | PF11976 | 0.498 |
LIG_TYR_ITIM | 135 | 140 | PF00017 | 0.430 |
LIG_WRC_WIRS_1 | 129 | 134 | PF05994 | 0.484 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.556 |
MOD_GlcNHglycan | 155 | 159 | PF01048 | 0.655 |
MOD_GSK3_1 | 154 | 161 | PF00069 | 0.383 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.402 |
MOD_N-GLC_2 | 53 | 55 | PF02516 | 0.562 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.591 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.451 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.312 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.249 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.375 |
MOD_NEK2_2 | 144 | 149 | PF00069 | 0.362 |
MOD_PKA_2 | 135 | 141 | PF00069 | 0.447 |
MOD_PKA_2 | 26 | 32 | PF00069 | 0.353 |
MOD_PKA_2 | 87 | 93 | PF00069 | 0.565 |
MOD_Plk_4 | 100 | 106 | PF00069 | 0.502 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.443 |
MOD_Plk_4 | 135 | 141 | PF00069 | 0.387 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.325 |
TRG_ENDOCYTIC_2 | 142 | 145 | PF00928 | 0.337 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.482 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.442 |
TRG_ER_diArg_1 | 148 | 151 | PF00400 | 0.341 |
TRG_ER_diArg_1 | 152 | 154 | PF00400 | 0.364 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0L0 | Leptomonas seymouri | 53% | 84% |
A0A0S4KJ92 | Bodo saltans | 33% | 68% |
A0A1X0PBJ7 | Trypanosomatidae | 30% | 74% |
A0A3R7M6T4 | Trypanosoma rangeli | 25% | 72% |
A0A3S7X8K2 | Leishmania donovani | 100% | 71% |
A4HBF2 | Leishmania braziliensis | 74% | 71% |
E9B5M5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 71% |
Q4Q2B1 | Leishmania major | 90% | 100% |
V5BW09 | Trypanosoma cruzi | 27% | 74% |